Mitochondrial biogenesis: a potential therapeutic target for osteoarthritis

被引:29
|
作者
Blanco, F. J. [1 ,2 ]
Fernandez-Moreno, M. [2 ,3 ]
机构
[1] Complexo Hosp Univ A Coruna CHUAC, Agrupac Estrateg CICA INIBIC, Inst Invest Biomed A Coruna INIBIC, Grp Invest Reumatol, Sergas, Spain
[2] Univ A Coruna UDC, Dept Med, La Coruna, Spain
[3] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Madrid, Spain
关键词
Mitochondrial dynamics; Mfn2; Osteoarthritis; MITOFUSIN; 2; ENDOPLASMIC-RETICULUM; DYNAMICS; PARKIN; FISSION; FUSION; MFN2;
D O I
10.1016/j.joca.2020.03.018
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Mitochondrial dysfunction of human articular chondrocytes is considered a hallmark of cartilage degradation and OA pathogenesis. Due to the huge number of cellular processes in which mitochondria is implicated, even in the closed context of cellular respiration, the term mitochondrial function can refer to a variety of features which include fusion and fission, turnover (biogenesis and mitophagy), and plasticity. Mitochondrial biogenesis and mainly mitochondrial fusion and reduced mitophagy, contribute to the metabolic disorder and inflammation that occurs during OA. Reduced MFN2 and increased PARKIN expression represent potential therapeutic targets for the treatment of joint cartilage degradation during the OA process. (c) 2020 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1003 / 1006
页数:4
相关论文
共 50 条
  • [11] Evaluation of MiR-181a as a potential therapeutic target in osteoarthritis
    Qian, Yuqiang
    Jiang, Jiannong
    Peng, Jun
    Wang, Qiang
    Shen, Yixin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (05) : 1069 - 1075
  • [12] Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke
    Song, Meiying
    Zhou, Yuan
    Fan, Xiang
    MOLECULAR NEUROBIOLOGY, 2022, 59 (05) : 3110 - 3123
  • [13] Unveiling the potential of mitochondrial dynamics as a therapeutic strategy for acute kidney injury
    Hao, Yajie
    Zhao, Limei
    Zhao, Jing Yu
    Han, Xiutao
    Zhou, Xiaoshuang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [14] Mitochondrial Quality Control: A Pathophysiological Mechanism and Therapeutic Target for Stroke
    Yang, Miaoxian
    He, Yu
    Deng, Shuixiang
    Xiao, Lei
    Tian, Mi
    Xin, Yuewen
    Lu, Chaocheng
    Zhao, Feng
    Gong, Ye
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 14
  • [15] Basic calcium phosphate deposition in the joint: a potential therapeutic target in osteoarthritis
    O'Shea, FD
    McCarthy, GM
    CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) : 273 - 278
  • [16] Novel Insights and Current Evidence for Mechanisms of Atherosclerosis: Mitochondrial Dynamics as a Potential Therapeutic Target
    Li, Dan
    Yang, Shengjie
    Xing, Yanwei
    Pan, Limin
    Zhao, Ran
    Zhao, Yixi
    Liu, Longtao
    Wu, Min
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [17] NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
    Roman-Blas, J. A.
    Jimenez, S. A.
    OSTEOARTHRITIS AND CARTILAGE, 2006, 14 (09) : 839 - 848
  • [18] Epigenetics as a Therapeutic Target in Osteoarthritis
    Nunez-Carro, Carmen
    Blanco-Blanco, Margarita
    Mariuxi Villagran-Andrade, Karla
    Blanco, Francisco J.
    de Andres, Maria C.
    PHARMACEUTICALS, 2023, 16 (02)
  • [19] Mitochondrial dynamics and biogenesis indicators may serve as potential biomarkers for diagnosis of myasthenia gravis
    Li, Lanqi
    Cai, Donghong
    Zhong, Huiya
    Liu, Fengbin
    Jiang, Qilong
    Liang, Jian
    Li, Peiwu
    Song, Yafang
    Ji, Aidong
    Jiao, Wei
    Song, Jingwei
    Li, Jinqiu
    Chen, Zhiwei
    Li, Qing
    Ke, Lingling
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (04)
  • [20] Mitochondrial Biogenesis, Mitochondrial Dynamics, and Mitophagy in the Maturation of Cardiomyocytes
    Ding, Qianqian
    Qi, Yanxiang
    Tsang, Suk-Ying
    CELLS, 2021, 10 (09)